Recs

9

5 Deathbed Stocks?

We've all heard of the "death rattle" -- the last gasp from a lost soul's lungs. Sometimes, we seem to hear it from the companies in which we invest. Revenue dries up. Margins contract. Profits evaporate. All these signs suggest that their condition is worsening -- a financial death rattle, if you will.

Stocks in sickbay
Don't assume that all such companies are goners. Some will barely cling to life, while others will make a full recovery. But here, we're seeking companies that have all but given up the ghost.

For help, we'll turn to the clever coroners at our 130,000-strong Motley Fool CAPS community, where members give the thumbs-up or thumbs-down to some 5,300 stocks. We've unearthed a handful of stocks that look like they might be headed six feet under, based on their rock-bottom one-star CAPS ratings.

Then we'll palpate their pulse with some quick tests for liquidity. Who knows, maybe we'll still find some signs of life! The current ratio and quick ratio (also called the "acid test" ratio) give us an idea of a company's ability to pay its bills. The Altman Z-Score suggests companies in danger of bankruptcy. Companies scoring 3.00 and above are considered safe, between 2.70 and 2.99 are "yellow flags," between 1.80 and 2.70 have a good chance of going bankrupt within two years, and those with scores below 1.80 have a nearly certain appointment with the cryptkeeper.

Here's today's list. The question is, are these companies only mostly dead, or have they already given up the ghost?

Stock

CAPS Rating

Current Ratio

Acid-Test Ratio

Altman Z-Score

Recent Price

Data Domain (Nasdaq: DDUP  )

*

4.0

3.7

6.49

$11.45

FUJIFILM (Nasdaq: FUJI  )

*

2.4

1.3

2.76

$21.49

Regeneron Pharmaceuticals (Nasdaq: REGN  )

*

6.2

6.1

2.03

$14.45

Speedway Motorsports (NYSE: TRK  )

*

0.9

0.7

1.43

$11.39

Toll Brothers (NYSE: TOL  )

*

5.8

1.7

2.55

$18.45

Sources: Motley Fool CAPS; Capital IQ, a division of Standard & Poor's.

We obviously don't know whether these companies are headed six feet under, so don't short them based on their appearance here. Moreover, some companies like software makers and financials don't neatly fit into the Altman Z-Score scale. Yet our primary screen remains those stocks to which CAPS investors have given one-star status, signifying that they may be destined to seriously underperform the market. July's deathbed candidate, auto parts maker Lear, recently said that it may still have to file for bankruptcy, despite winning concessions from lenders.

Haunted mansions
Ben Bernanke says the Fed wants to pump $1.2 trillion into the economy as a way to further lower mortgage rates. With rates this low, you'll be forgiven for wondering why they're bothering to charge any mortgage interest at all. After all, rates have already fallen below 5% for a 30-year fixed, the lowest level since January.

High interest rates aren't the bane of Toll Brothers, Centex (NYSE: CTX  ) , and KB Homes (NYSE: KBH  ) ; they're suffering far more from a glut of inventory on the market. Although the surprise 22% jump in new home construction in February gave homebuilder stocks a boost, building a home doesn't equate to selling one. The most current data from January showed that new-home sales sank 50%, the sixth monthly decline in a row, with the supply of new homes at the current sales rate on the market rising to more than 13 months.

If Toll Brothers and the other builders want to build even more homes, deluding themselves into thinking their market has finally hit bottom, that doesn't mean investors need to follow them. As CAPS member assistryan notes, Toll is famous for its McMansion-style of building, on the opposite end of the market from the sort of homes that will likely lead the recovery:

The housing industry still has a long way to fall. Tolls' wheel house is mid to upper end mcmansions. Tighter credit is hitting this price range the worst. As the market stabilizes the lower end will recover first, follow at least 2-3 years later by the upper end market. In addition the majority of the markets around the country are way over built. It is still going to take years to clean up inventory levels.

Rattling the cage
Are these companies doomed to drag their investors into an underworld of underperformance? Or will they be resurrected to stalk the markets once again? It pays to start your own research on these stocks on Motley Fool CAPS. Read a company's financial reports, scrutinize key data and charts, and examine the comments your fellow investors have made, all from a stock's CAPS page. Sign up today, absolutely free, and let us know whether you think the Grim Reaper's at the door.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Try any of our Foolish newsletter services free for 30 days.

Fool contributor Rich Duprey does not have a financial interest in any of the stocks mentioned in this article. You can see his holdings here. The Motley Fool's disclosure policy is full of life.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 19, 2009, at 9:36 PM, ferdberfl wrote:

    DDUP? Maybe i'm a little slow. As of their last quarter they had $233M in cash. 0 Debt. How is that on the deathbed. Again maybe i'm confused, if an Altman-Z score of 3 or above is safe, isn't a score of 6.49 higher than 3.0?

    Perhaps you mean QTM: $51M in cash, $409M in debt with much of it due in less than a year. What's their Altman-Z score?

  • Report this Comment On March 19, 2009, at 9:47 PM, ferdberfl wrote:

    QTM: from fool.com's own data:

    Financial Strength

    Quick Ratio 0.80

    Current Ratio 1.30

  • Report this Comment On March 23, 2009, at 7:16 PM, peterdworkin wrote:

    You are doing a disservice to your readers as well as to our company and its shareholders to suggest that Regeneron is in perilous financial condition. Your own information on our current and quick ratios shows we have ample resources to pay our short-term liabilities. The third metric you cite, our Altman score, is influenced mainly by sales and earnings and therefore is a misleading and inappropriate metric for biotechnology companies that are developing drugs and who are not yet profitable. More pertinent are our current cash and projected burn rate, and therefore it is surprising that you failed to mention that Regeneron had, at the end of 2008, $527 million in cash and marketable securities and absolutely zero debt. Our current financial resources, supplemented by committed partner funding from sanofi-aventis and Bayer Healthcare, are expected to support operations through 2012. Additionally, your readers should be aware that next year we expect to report efficacy and safety data from three Phase 3 clinical trial programs.

    Peter Dworkin

    Vice President,

    Investor Relations and Communications

    Regeneron Pharmaceuticals, Inc.

  • Report this Comment On March 23, 2009, at 10:50 PM, TMFCop wrote:

    peterdworkin,

    Thanks for sharing your thoughts about Regeneron here. I agree that REGN's numbers look good, and pharmaceuticals often have such numbers that are off the charts.

    We do note that not every type of business is usefully tracked by the various metrics, but as always, the primary screen for a stock to make this list are CAPS members marking it down to the one-star rating level. The other items are intended to provide further information to encourage an investor to perform his own due diligence and to NOT use this list as a buy or sell formula.

    I'll also note that we do look back every month at stocks picked previously to see how they have performed, and while quite a number of companies that have appeared here have ultimately "bit the dust," a handful or more have gone on to confound the markets. Perhaps we'll see REGN on this latter list.

    Once again, thanks for sharing your thoughts about the company.

    Rich

  • Report this Comment On March 23, 2009, at 10:56 PM, tomd728 wrote:

    Hey guys................

    "Let's get our stories straight !!!!"

    Or who dropped the baby on the way to

    the tub ?

    Then we may not be too consumed with:

    "Throwing the baby out with the bath water."

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 855711, ~/Articles/ArticleHandler.aspx, 2/13/2012 2:48:13 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 12,801.23 -89.23 -0.69%
S&P 500 1,342.64 -9.31 -0.69%
NASD 2,903.88 -23.35 -0.80%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/10/2012 4:02 PM
TOL $23.31 Down -0.39 -1.65%
Toll Brothers, Inc… CAPS Rating: **
KBH $11.71 Down -0.27 -2.25%
KB Home CAPS Rating: *
REGN $102.08 Down -1.52 -1.47%
Regeneron Pharmace… CAPS Rating: **
TRK $16.40 Down -0.10 -0.61%
Speedway Motorspor… CAPS Rating: *
CTX $11.95 Down +0.00 +0.00%
Centex Corp CAPS Rating: *
DDUP $33.52 Down +0.00 +0.00%
Data Domain, Inc. CAPS Rating: *
FUJI $31.97 Down +0.00 +0.00%
FUJIFILM Holdings… CAPS Rating: *

Advertisement